RANKL increases the level of Mcl-1 in osteoclasts and reduces bisphosphonate-induced osteoclast apoptosis in vitro
IntroductionBisphosphonates are the most widely-used party of narcotic for inhibiting osteoclast-mediated bone loss, on the contrary their effectiveness at preventing seam destruction in rheumatoid arthritis has generally been disappointing. We examined if the energy of bisphosphonates to induce osteoclast apoptosis and inhibit bone resorption in vitro is influenced by the cytokine receptor activator of NFkappaB ligand (RANKL), an important mediator of inflammation-induced bone loss. Methods: Rabbit osteoclasts were treated with the bisphosphonates clodronate or alendronate for up to 48 hours in the absence or presence of RANKL. Changes in cell morphology and induction of apoptosis were examined by scanning electron microscopy, while resorptive labor was firm by measuring the universe of resorption cavities.
Do synovial biopsies help to support evidence for involvement of innate immunity in the immunopathology of Beh ccedil;et's disease?
Behcet's disease is a complex vasculitis of distant etiology. Filled neutrophils propose innate immunity involvement. Cytokines are skewed to the Th1-pattern. Few sterile organs are easily accessible for conversation in Behcet's disease. Canete et al. show inflamed joints as a credible pattern and suggest involvement of innate immunity in Behcet's disease.
Effects of cyclophosphamide on pulmonary function in patients with scleroderma and interstitial lung disease: a systematic review and meta-analysis of randomized controlled trials and observational prospective cohort studies
No summary available
Correction: Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
No summary available
Post-translational aging of proteins in osteoarthritic cartilage and synovial fluid as measured by isomerized aspartate
IntroductionAging proteins undergo non-enzymatic post-translational refashioning including isomerization and racemization. We hypothesized that cartilage, with frequent long-lived components could accumulate non-enzymatically modified amino acids in the embodiment of isomerized aspartate and that its liberation due to osteoarthritis (OA) related cartilage degradation could mirror OA severity. Methods: Articular cartilage and synovial fluid were obtained from 14 randomly selected complete knee arthroplasty cases (aged 56 to 79 years) and non-arthritis cartilage from 8 trauma cases (aged 51 to 83 years). Paired lesional and non-lesioned OA cartilage was graded histologically using a modified Mankin system.
Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis
No abstract available
Progress in Spondylarthritis. Mechanisms of new bone formation in spondyloarthritis
Targeted therapies neutralizing tumour necrosis instrument can very generally adequately control signs and symptoms of spondyloarthritis. However, new animal imitation data and clinical observations instruct that discipline of inflammation may not be sufficient to influence disease method towards ankylosis in these patients. Bone morphogenetic proteins and WNTs are credible to play an important role in ankylosis and could be therapeutic targets. The correlation between inflammation and new bone formation is even unclear. This review summarizes success prepared in our understanding of ankylosis and offers an alternative contour on the conjunction between inflammation and ankylosis.
Complex genetic association of 6q23 with autoimmune rheumatic conditions
In a paper by Dieguez-Gonzalez and colleagues in this concern of Arthritis Research & Therapy, the results of a detailed genetic investigation of the recently identified rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE) susceptibility region at 6q23 containing the tumor necrosis factor alpha-induced protein 3 (TNFAIP3) gene are reported. Their news confirms the knotty constitution of the association involving both the TNFAIP3 locus and a region >150 kb upstream region that does not encode any be cognizant gene. This material is consistent with fresh studies of SLE susceptibility confirming distinct independent genetic contributions to autoimmune rheumatic diseases arising from 6q23.
Rheumatoid cachexia: a complication of rheumatoid arthritis moves into the 21st century
Rheumatoid cachexia (RC) is loss of muscle mass and strength, and concomitant augmentation in fat mass, is besides common in patients with rheumatoid arthritis (RA). In spite of fat advances in the treatment of RA, it appears that RC persists even after seam inflammation improves. RC may be an considerable risk factor for cardiovascular disease and excess mortality in RA. In this belief of Arthritis Research & Therapy, Elkan et al. prove a link between RC and metabolic syndrome, extremely reinforcing the duty for therapy directed beyond inflammation, at the metabolic consequences of RA.
The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus
The increased anxiety of cardiovascular disease in patients with rheumatoid arthritis and systemic lupus erythematosus has recently shift the nerve center of close investigation. Proatherogenic risk factors and dysregulated inflammation are the leading culprits, leading to enhanced atherosclerosis in subgroups of patients with inflammatory diseases. Colloquial molecular pathways shared by atherosclerosis and inflammatory disease may be involved. In this check we map the gloss determinants of the increased incidence of cardiovascular disease in patients with inflammatory diseases at each process of the atherogenesis.
